Speak to a world-class expert now.
1-800-FOR-KKAI (1-800-367-5524)
info@kkai.com
PrimeTrack® Instant Conferencing
PrimeTrack® Project Management System (patent pending)
Consultant
WHN is a Scientist, Biopharmaceutical Product and Process Development Consultant, Nucleic Acids Assay Development Specialist with world-class expertise in product and process development, including knowledge of moving biopharmaceutical products through an R&D pipeline to manufacturing, IND filing and clinical trial.
Speak to this experienced, world-class expert now.
For additional or different expertise, browse other top-level expert resumes in Expert Testimony, Failure Analysis, Manufacturing Optimization, KKAI's Center for Rapid Response Engineering® Solutions and a host of other Engineering and Scientific Consulting services.
Learn how KKAI assembles expert teams of any size or skill set combination to meet our clients' needs on a rapid-response basis - no matter how complex the challenge.
Or, peruse our 400 case studies or 500 other expert resumes.
Diphtheria toxin protein secreted by pathogenic strains of Corynebacterium diphtheriae is the causative agent for diphtheria in humans. CRM197 protein that is used for vaccination against diphtheria is a non-toxic mutant derivative of the diphtheria toxin resulting from G-->A transition in the tox gene encoding a GLY-->GLU substitution in position 52 of the protein amino acid sequence. Considering the possibility of CRM197 allele reversion to wild-type tox gene sequence during cultivation of bacteria, it is extremely important to monitor the genetic stability of CRM197 mutation in process of protein production. For that purpose we have designed a method for quantitation of a particular gene allele in DNA mixtures by means of restriction fragment length polymorphism (RFLP) in combination with polymerase chain reaction (PCR).
We have applied the quantitative RFLP principle for estimation of the relative amount of diphtheria toxin gene CRM197 allele in DNA samples isolated from the cultures of Corynebacterium diphtheriae. The procedure presented in Figure1, is based on PCR-mediated generation of an artificial Alu I restriction site specifically with the CRM197 DNA template. After Alu I digestion of the PCR product and polyacrylamide gel electrophoresis of the restriction fragments, the percentage of CRM197 template in the initial DNA sample was determined by scanning a gel negative as shown in Figure 2 and calculated as shown in Figure 3. The method produced a linear response in the range of 0-100% of CRM197 reference template DNA in the sample (Figure 4) with a detection limit of 5% (Figure 3).
| Scientist, Biopharmaceutical Product and Process Development Consultant, Nucleic Acids Assay Development Specialist, product and process development, including knowledge of moving biopharmaceutical products through an R&D pipeline to manufacturing, IND filing and clinical trial. | |
| Resume of TRM | pharmaceutical, biotechnology expert consultant |
| Resume of BYT | regulatory compliance, validation expert consultant |
| Resume of VHN | pharmaceutical, nutraceutical manufacturing expert consultant |
| Resume of CHL | biotechnology, product, process validation, expert consultant |
| Resume of FXT | diesel engine manufacturing, new product expert consultant |
To search for specific expertise, enter your search query (type of
expertise you are seeking) in the box below, choose to search the entire
Rapid-Response site or just resumes and brochures, then click the search button.
Please note that the list of resumes available online is a select subset of our
vast database. If your search of our site does not reveal the expertise you are
seeking, please call us toll-free (in the U.S.) at 1-800-367-5524 or
contact us for more information and we will gladly assist you in
locating the specific expertise you require.
Have an urgent litigation support or engineering and scientific consulting need? Contact KKAI now for world-class, expert rapid response.
1-800-FOR-KKAI (1-800-367-5524)
info@kkai.com
BACK TO THE TOP OF THIS PAGE
Kevin Kennedy & Associates, Inc.
Rapid Response Engineering® Solutions
3905 Vincennes Road, Suite 320
Indianapolis, Indiana 46268
(317) 536-7000 voice
(317) 536-7220 fax